Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000804210 | SCV000944106 | uncertain significance | Wilson disease | 2021-08-12 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 4 of the ATP7B gene. It does not directly change the encoded amino acid sequence of the ATP7B protein. It affects a nucleotide within the consensus splice site of the intron. This variant is present in population databases (rs781531824, ExAC 0.001%). This variant has been observed in individual(s) with Wilson disease (PMID: 9801873). This variant is also known as c.1703+3insT. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV000804210 | SCV001977180 | uncertain significance | Wilson disease | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000804210 | SCV004216347 | likely pathogenic | Wilson disease | 2024-03-10 | criteria provided, single submitter | clinical testing |